These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16786254)

  • 1. Copper concentration of liver tissue under long-term copper-histidine therapy in a patient with Menkes disease.
    Kroepfl T; Mair E; Deutsch J; Brunner-Krainz M; Paschke E; Plecko B
    J Inherit Metab Dis; 2006 Aug; 29(4):593. PubMed ID: 16786254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menkes' kinky hair syndrome.
    George S; Matthai SA; Sosamma MM; Sukumaran TU
    Indian J Pediatr; 2005 Oct; 72(10):891-2. PubMed ID: 16272669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intramuscular copper histidine treatment in Menkes disease].
    Nakamoto N; Hamaguchi H; Naito H; Nihei K
    No To Hattatsu; 1992 May; 24(3):296-8. PubMed ID: 1591032
    [No Abstract]   [Full Text] [Related]  

  • 4. Early copper histidine therapy in classic Menkes disease.
    Sarkar B
    Ann Neurol; 1997 Jan; 41(1):134-6. PubMed ID: 9005880
    [No Abstract]   [Full Text] [Related]  

  • 5. Infantile spasms and Menkes disease.
    Sfaello I; Castelnau P; Blanc N; Ogier H; Evrard P; Arzimanoglou A
    Epileptic Disord; 2000 Dec; 2(4):227-30. PubMed ID: 11174154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menkes disease mutations and response to early copper histidine treatment.
    Kaler SG
    Nat Genet; 1996 May; 13(1):21-2. PubMed ID: 8673098
    [No Abstract]   [Full Text] [Related]  

  • 7. In utero copper treatment for Menkes disease associated with a severe ATP7A mutation.
    Haddad MR; Macri CJ; Holmes CS; Goldstein DS; Jacobson BE; Centeno JA; Popek EJ; Gahl WA; Kaler SG
    Mol Genet Metab; 2012 Sep; 107(1-2):222-8. PubMed ID: 22695177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative abnormalities in Menkes disease.
    Rizzo C; Bertini E; Piemonte F; Leuzzi V; Sabetta G; Federici G; Luchetti A; Dionisi-Vici C
    J Inherit Metab Dis; 2000 Jun; 23(4):349-51. PubMed ID: 10896291
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of copper-histidine therapy on brain metabolism in a patient with Menkes disease: a proton magnetic resonance spectroscopic study.
    Munakata M; Sakamoto O; Kitamura T; Ishitobi M; Yokoyama H; Haginoya K; Togashi N; Tamura H; Higano S; Takahashi S; Ohura T; Kobayashi Y; Onuma A; Iinuma K
    Brain Dev; 2005 Jun; 27(4):297-300. PubMed ID: 15862194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function in patients with Menkes disease.
    Ozawa H; Kodama H; Kawaguchi H; Mochizuki T; Kobayashi M; Igarashi T
    Eur J Pediatr; 2003 Jan; 162(1):51-2. PubMed ID: 12607531
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Menkes disease with parenteral copper histidine.
    Kirodian BG; Gogtay NJ; Udani VP; Kshirsagar NA
    Indian Pediatr; 2002 Feb; 39(2):183-5. PubMed ID: 11867850
    [No Abstract]   [Full Text] [Related]  

  • 12. Copper histidinate therapy in Menkes' disease: prevention of progressive neurodegeneration.
    Sherwood G; Sarkar B; Kortsak AS
    J Inherit Metab Dis; 1989; 12 Suppl 2():393-6. PubMed ID: 2512453
    [No Abstract]   [Full Text] [Related]  

  • 13. Menkes' Kinky Hair disease: new considerations.
    Kabra M; Gangakhedkar AK; Pasi GR; Manoj R; Verma IC
    Indian Pediatr; 1996 Nov; 33(11):956-60. PubMed ID: 9141833
    [No Abstract]   [Full Text] [Related]  

  • 14. Menkes' kinky-hair disease: radiologic findings in a patient treated with copper histidinate.
    Waslen TA; Houston CS; Tchang S
    Can Assoc Radiol J; 1995 Apr; 46(2):114-7. PubMed ID: 7704673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menkes disease after copper histidine replacement therapy: case report.
    George DH; Casey RE
    Pediatr Dev Pathol; 2001; 4(3):281-8. PubMed ID: 11370266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menkes disease: importance of diagnosis with molecular analysis in the neonatal period.
    Costa LS; Pegler SP; Lellis RF; Krebs VL; Robertson S; Morgan T; Honjo RS; Bertola DR; Kim CA
    Rev Assoc Med Bras (1992); 2015; 61(5):407-10. PubMed ID: 26603002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper-histidine therapy for Menkes disease.
    Sarkar B; Lingertat-Walsh K; Clarke JT
    J Pediatr; 1993 Nov; 123(5):828-30. PubMed ID: 8229500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Síntesis y uso de histidinato de cobre en niños con enfermedad de Menkes en México.
    Flores-Pulido AA; Jiménez-Pérez VM; García-Chong NR
    Gac Med Mex; 2019; 155(2):191-195. PubMed ID: 31056589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of cerebrospinal fluid copper in Menkes kinky hair disease.
    Kollros PR; Dick RD; Brewer GJ
    Pediatr Neurol; 1991; 7(4):305-7. PubMed ID: 1930426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of intracerebroventricular copper histidine in adult rats.
    Lem KE; Brinster LR; Tjurmina O; Lizak M; Lal S; Centeno JA; Liu PC; Godwin SC; Kaler SG
    Mol Genet Metab; 2007 May; 91(1):30-6. PubMed ID: 17336116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.